Gilteritinib for the Treatment of ALK NSCLC

NCT06225427 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
DRUG: Gilteritinib
PROCEDURE: Magnetic Resonance Imaging
OTHER: Questionnaire Administration

Sponsor

University of Michigan Rogel Cancer Center